Background-Transesophageal echocardiogram (TEE) is considered the gold standard modality in detecting left atrial/ LA appendage (LA/LAA) thrombi. However, this is a semi-invasive procedure with rare but potential life-threatening complications. Cardiac computed tomography has been proposed as an alternative method. The purpose of this metaanalysis was to evaluate the diagnostic accuracy of cardiac computed tomography assessing LA/LAA thrombi in comparison with TEE. Methods and Results-A systematic review of Medline, Cochrane, and Embase to look for clinical trials assessing detection of LA/LAA thrombi by cardiac computed tomography when compared with TEE in patients with a history of atrial fibrillation before electric cardioversion/pulmonary vein isolation or after cardioembolic cerebrovascular accident was performed using standard approach and bivariate analysis. Nineteen studies with 2955 patients (men, 71%; mean age, 61±4 years) fulfilled the inclusion criteria. Most studies (85%, 16 studies) used 64-slide multidetector computed tomography and 15 studies (79%) were electrocardiographic-gated. The incidence of LA/LAA thrombi was 8.9% (SD, ±7). The mean sensitivity and specificity were 96% and 92%, whereas the positive predictive value and negative predictive value were 41% and 99%, respectively. The diagnostic accuracy was 94%. In a subanalysis of studies in which delayed imaging was performed, the diagnostic accuracy significantly improved to a mean weighted sensitivity and specificity of 100% and 99%, respectively, whereas the positive predictive value and negative predictive value increased to 92% and 100%, respectively. The accuracy for this technique was 99%. Conclusions-Cardiac computed tomography, particularly when delayed imaging is performed, is a reliable alternative to TEE for the detection of LA/LAA thrombi/clot, avoiding the discomfort and risks associated with TEE. (Circ Cardiovasc Imaging. 2013;6:185-194.)
A trial fibrillation (AF) and associated cardioembolic cerebrovascular accidents (CVAs) are 2 well-known major healthcare problems worldwide. 1, 2 It has been estimated that 2.2 million people in America and 4.5 million in the European Union have paroxysmal or persistent AF. 3 Likewise, the annual incidence of new or recurrent stroke in the United States is ≈795 000 of which ≈87% are because of ischemia. 4 AF is associated with an increased long-term risk of stroke. 5 The rate of ischemic stroke among patients with nonvalvular AF averages 5% per year. [6] [7] [8] 
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Transesophageal echocardiogram (TEE) is considered the gold standard modality in detecting left atrial/LA appendage (LA/LAA) thrombi in patients with ischemic CVA of suspected cardioembolic pathogenesis or with AF undergoing electric cardioversion (EC) or pulmonary vein isolation (PVI) because it provides superior visualization of posterior structures, such as the LA and LAA, when compared with transthoracic echocardiography (TTE). 9 TEE has been demonstrated to be an accurate modality based on 2 large prospective studies. The first one with a thrombi prevalence of 5.2% showed a sensitivity of 100%, a specificity of 99% with a positive predictive value (PPV) of 86% and a negative predictive value (NPV) of 100%. 10 In the second study, with a LA/LAA thrombus prevalence of 15%, all thrombi were confirmed at surgicopathologic studies (specificity 100%).
However, in 2 patients, LA thrombi were present but could not be detected by TEE (sensitivity, 93.3%). Furthermore, the PPV was 100%, the NPV was 98.9%, and the diagnostic accuracy was 99.1%. 11 Likewise, TEE findings indicative of atrial stasis or thrombosis have been independently associated with high thromboembolic risk in patients with AF. 9 TEE is a semi-invasive procedure generally safe in experienced hands. Nevertheless, it is time-consuming, carries physical discomfort, is not readily available at all times, and it is associated, although rarely, with potential life-threatening complications. 12 During the past decade, cardiac computed tomography (CCT) and cardiac MRI (CMR) have been tested for the detection of LA/LAA thrombi. Moreover, these imaging modalities are commonly used in clinical practice for guidance of PVI procedures. Of these, CCT has been more widely investigated, showing high sensitivity, although variable specificity for the detection of LA/LAA thrombus.
In the following meta-analysis, we scrutinize the accuracy of CCT in the evaluation of LA/LAA thrombi in the available literature when compared with TEE.
Methods

Search Strategy
The objective of the current analysis was to evaluate the available studies, in which CCT was compared with TTE for the detection of LA/ LAA thrombi in patients undergoing EC or PVI for persistent or paroxysmal AF and in subjects being evaluated for cardioembolic CVA.
We searched PubMed, Embase, and Cochrane Central Register of Clinical Trials (Cochrane Library, Issue 4, 2012) using the terms (left atrial thrombus OR left atrial appendage OR left atrial appendage thrombus OR left atrial clot OR left atrial appendage thrombi OR left atrial appendage filling defects OR Left atrial thrombi or atrial thrombus) AND (64-Slice multidetector CT OR 64-Slice multidetector computed tomography OR computed tomography OR cardiac CT OR CT OR CCT). We limited our search to humans in peer-reviewed journals from 1966 to May 2012. No language restriction was applied. The reference lists of bibliographies of identified articles were also reviewed.
Selection Criteria
To be included in the analysis, a trial had to fulfill the following criteria: (1) the study was either prospective or retrospective (only if both TEE and CCT were performed consecutively within 7 days) involving patients who underwent both CCT and TEE evaluation to rule out LA/LAA thrombi before PVI/EC for AF or as part of stroke assessment; (2) the study allowed for sensitivity, specificity (NPV), and (PPV) calculations.
Data Extraction
Two authors (J.R. and S.H.) extracted the data independently and in duplicate. Data were extracted using standardized protocol and reporting forms. Disagreements were resolved by arbitration (J.R. or M.G.), and consensus was reached after discussion. We extracted characteristics of each trial, interval between CCT and TEE, CCT methodology (eg, ECG-gated versus non-ECG-gated), and baseline patient demographics for our analysis. In instances where these values were not readily available, the principal investigator of that particular trial was approached to supply the relevant information.
Quality Assessment
To assess the quality and reporting of studies, we evaluated 14 items that were considered relevant to the review topic, based on the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) instrument. 13 Two reviewers (J.R. and S.H.) independently assessed the quality items, and discrepancies were resolved by consensus. These items covered patient spectrum, reference standard, disease progression bias, verification bias, review bias, clinical review bias, incorporation bias, test execution, study withdrawals, and indeterminate results among others.
Statistical Analysis
Sensitivities (number of thrombi detected by the index test [CCT] divided by the total number of thrombi detected by the reference In this meta-analysis, we estimated summary sensitivity and specificity using a more recently developed bivariate random effects model instead. 14, 15 The bivariate approach assumed logit transforms of sensitivity and specificity from individual studies are from a bivariate normal distribution. The bivariate approach is considered to be a better approach as compared with the standard summary receiver operating characteristics (ROC) approach 16 because first, it assesses heterogeneity across studies in sensitivity and specificity and provides a summary estimate of sensitivity and specificity; second, it models sensitivity and specificity jointly so that a 95% confidence ellipse around the summary estimate can be calculated; third, it allows one to directly compare sensitivity and specificity between methods; furthermore, several choices are available to obtain a summary ROC curve. 14, 15 In this article, the summary ROC curve was obtained by transforming the regression line of logit sensitivity on logit specificity into ROC space. 14 A similar bivariate approached was used to model PPV and NPV. 17 Publication bias was assessed for each analysis using Peter and Harbord methods.
We assessed between-study heterogeneity visually, by plotting sensitivity and specificity in the ROC curves. We also drew summary ROC curves and confidence regions for summary sensitivity and specificity. 15, 18 The analyses were conducted using STATA 12 (Metandi Syntax), and the figures were generated using STATA graph editor.
Sensitivity Analysis
We further evaluated whether the performance of each technique depends on features of the technique (eg, ECG-gated versus non-ECG-gated) and patient characteristics. We also performed a detailed sensitivity analysis to identify whether inclusion of retrospective studies had a significant impact on the overall results of this metaanalysis. A logistic regression for each technique was used to model the sensitivity on these factors.
Results
Study Selection
We identified 1800 abstracts, of which 29 articles were retrieved and reviewed for possible inclusion (Figure 1 ). Nineteen studies with a total of 2955 patients fulfilled the inclusion criteria and were included in the meta-analysis. Five studies were excluded from the final analysis because they did not meet the inclusion criteria: 1 study had both a prolonged time interval between CCT and TEE (ie, mean 30 days) and ≈50% of the patients enrolled underwent TTE instead of TEE, 19 another also had a prolonged time interval between CTT and TEE (ie, mean time between multidetector computed tomography [MDCT] and TEE 10.7±16.3 days), 20 1 study assessed LA/LAA morphology (eg, multilobed LAA, LA diameter, etc) instead of thrombus, 21 and 2 studies did not provide enough data to calculate diagnostic accuracies. 22, 23 
Baseline Characteristics
A total of 19 studies [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] with 2955 patients (mean age, 61 years [SD, ±4]; men, 71%) with AF undergoing PVI/EC or patients with CVA being worked-up for cardioembolic source were included ( Table 1 ). The overall incidence for LA/LAA thrombi was 8.9% (SD, ±7). Twelve studies (74%) were prospective and 5 (26%) were designed retrospectively performing both tests in a consecutive fashion within 1 week. Eleven studies were performed before PVI, 7 studies after CVAs, and 1 study before EC. Most studies (85%, 16 studies) used 64-slide MDCT and only 1 study used electron-beam computed tomography. Electrocardiographic-gated (ECG-gated) CCT protocols were performed in 15 studies (79%) with delayed phase images obtained only in 7 studies (37%). The average slice thickness was 0.6 mm.
Sensitivity Analysis
We examined every variable included in the baseline characteristics table (eg, study design, percentage of men, ECG-gated versus non-ECG-gated, whether or not β-blockers were used, average heart rate, type of CCT, and slice thickness; Table  1 ). No factor was identified that had a significant influence on its sensitivity. However, when we performed a sensitivity analysis for comparing studies that used delayed imaging versus those that did not, we found a significant impact on the specificity of CCT showing that the former had a remarkably higher PPV ( Table I in More importantly, our sensitivity analysis on the impact of including retrospective studies in our final results did not show any statistical significance when compared with the overall diagnostic accuracies if only prospective studies had been included in this meta-analysis. We performed this analysis for both (1) all CT studies and (2) delayed phase imaging studies ( Table II in 
Quality Assessment
Reporting was slightly poor on items 10 and 11 (Were the index test results interpreted without knowledge of the results of the reference standard?) and (Were the reference standard results interpreted without knowledge of the results of the index test?), respectively, on the study by Tang et al. 29 This might have led to overestimation of diagnostic accuracy (review bias). Nevertheless, this trial had one of the lowest sensitivities and PPVs of all studies included in this meta-analysis. Achenbach et al, 34 did not report the time interval between tests, which might have introduced disease progression bias. Likewise, Maltagliati et al, 24 failed to report a detailed explanation of the execution of the index test to permit its replication in clinical practice. Otherwise, all the studies showed high-quality scores in the remaining 13 items of QUADAS ( Figure I and II in the online-only Data Supplement).
Publication Bias
Using Peter's method, there was no indication of publication bias (P value of 0.78). Conversely, using Harbord's test there was indication of publication bias (P value of 0.004). This might indicate that some studies reporting negative results for this technique might not have been submitted for publication, and if they were, they were never published.
Diagnostic Accuracy for All CCT Studies
The weighted mean sensitivity and specificity were 96% (95% confidence interval [CI], 92%-100%) and 92% (95% CI, 91%-93%), whereas the PPV was 41% (95% CI, 37%-44%) and NPV was 99% (95% CI, 99%-100%), respectively ( Table  2) . CCT had a weighted overall accuracy of 94% (95% CI, 91%-96%). Figure 2A through 2D demonstrates the overall weighted sensitivity, specificity, and predictive values (random effects analysis).
Delayed Phase Images Studies
Baseline Characteristics
On sensitivity analysis (Table 1 ), the 7 studies enrolled a total of 753 patients (mean age, 61±4 years; men, 70%) and had an overall incidence for LA/LAA thrombi of 14±8%. Six studies were prospective (86%). All studies were ECG-gated. Likewise, different parameters (ie, contrast volume, delayed time, slice thickness, and kVp) used in delayed imaging protocols are shown in Table III in the online-only Data Supplement.
Diagnostic Accuracy
In these studies, the mean weighted sensitivity and specificity were 100% (95% CI, 96%-100%) and 99% (95% CI, 98%-100%), whereas the PPV and NPV were 92% (95% CI, 86%-98%) and 100% (95% CI, 99%-100%), respectively ( Table 3 ). The weighted overall accuracy for this technique was 99% (95% CI, 98%-100%). It was noticed that, using delayed images improved the PPV from 41% (all studies combined) or from 26% (early phase images studies) to 92% (P<0.001) making CCT as accurate as TTE for the detection of LA/LAA thrombus. Figure 2A through 2D demonstrates the overall weighted sensitivity, specificity, and predictive values comparing early versus delayed phase image studies (random effects analysis).
PVI Studies
Baseline Characteristics
A total of 11 studies with a total of 1836 patients (mean age, 64 years [SD, ±3]; men, 75%) with AF undergoing PVI were included. The overall incidence for LA/LAA thrombi was 5.8% (SD, ±5). Seven (64%) were prospective and 4 (36%) were designed retrospectively performing both tests in a consecutive fashion within 1 week. Eight studies (73%) were ECG-gated. Most studies were performed using 64-slice MDCT, 1 study used 4-slice MDCT with 3-dimensional (3D) reconstruction and another one used dual-source computed tomography.
Diagnostic Accuracy
In these studies, the mean weighted sensitivity and specificity were 91% (95% CI, 85%-97%) and 95% (95% CI, 94%-96%), whereas the Upland NPV was 33% (95% CI, 28%-38%) and 100% (95% CI, 99%-100%), respectively. The weighted overall accuracy for this technique was 95% (95% CI, 94%-96%). Similarly, when delayed imaging protocols were performed, the diagnostic accuracy of CCT significantly improved. Sensitivity and specificity were 100% (95% CI, 83%-100%) and 100% (95% CI, 98%-100%), whereas the Upland NPV was 100% (95% CI, 98%-100%) and 100% (95% CI, 99%-100%), respectively. The weighted overall accuracy for this technique was 100% (95% CI, 98%-100%).
Finally, the bivariate model showing combined summary diagnostic accuracies, 95% CI, and 95% predictive region in summary ROC curves for all studies using only early phase imaging and those adding delayed phase imaging is displayed in Figure 3A through 3C. These ROCs clearly demonstrate that the 95% confidence region and the 95% prediction region are much smaller in the group with delayed phase images studies than in the 2 other groups (overall and early phase images studies) indicating that the former group has a much lower heterogeneity.
Discussion
Our meta-analysis demonstrated overall high accuracy of CCT compared with TEE for the detection of LA/LAA thrombus in patients with AF. When delayed CT imaging is used, the accuracy of CT is even higher with sensitivity, specificity, PPV, NPV, and accuracy >92%.
Despite the fact that TEE has a considerable number of applications in clinical practice including but not limited to evaluation of valvular disease and aortic pathology, it is most commonly ordered to guide anticoagulation therapy in patients with AF or atrial flutter in the setting of stroke, cardioversion, and radiofrequency ablation.
TEE has been validated as a fairly accurate tool for the detection of LAA/LA thrombi/clot in studies comparing its results with intraoperative findings, 5 and this is the reason why the 2011 American College of Cardiology Foundation/ American Heart Association/Heart Rhythm Society-focused updates incorporated into the American College of Cardiology/ American Heart Association/European Society of Cardiology 2006 guidelines for the management of patients with AF recommend TEE as the only imaging modality for this purpose. 41 However, for some patients, TEE may be an uncomfortable and a time-consuming procedure. Although extremely unusual, life-threatening complications have been reported in the literature. 12 It also has a few absolute and some relative contraindications making reliable alternative imaging modalities a growing need in contemporary clinical practice. Consequently, newer imaging modalities, such as CCT, has been tested and compared with TTE during the past decade for the diagnosis of LA/LAA thrombi.
The diagnostic accuracy of CCT has been extensively studied indicating a high NPV. Nonetheless, there have been major discrepancies between reported PPVs and accuracy estimates. As a result CCT has not been included in practice guidelines for evaluation of patients with AF. This is unfortunate because many patients are more often being evaluated by this modality for a variety of clinical indications, including 3D guidance of PVI procedures.
This meta-analysis clearly demonstrates that CCT can play a critical role in the detection of LLA/LA thrombi/clot before ECCV, PVI and in the evaluation for cardiovascular source of embolus in patients experiencing ischemic CVA with a weighted sensitivity and a specificity of 96% and 92% and PPV and NPV of 41% and 99%, respectively. Its overall diagnostic accuracy was 94%.
As expected, the low PPV was because, in part, of the low prevalence of the disease (ie, 8.9% for all studies and 14% delayed phase images studies), in this case the presence of LAA/LA thrombi/clot in the studied population. Nevertheless, this is an accurate estimate of the LAA/LA thrombi/clot in clinical practice for nonvalvular AF (ie, 5%-15%). [42] [43] [44] In addition, the criteria used to determine the presence of thrombus relies in the detection of regions of low attenuation. Because the CCT study is static and the images are captured a few seconds after arrival of contrast to the left heart (LA/LAA), it Segments are given as % (n/N). NPV indicates negative predictive value; and PPV, positive predictive value. is difficult to differentiate thrombus from sluggish flow. The addition of delayed imaging allows a better distinction of both conditions. Hence, a filling defect that persists 1 minute after contrast injection is more likely to represent thrombus, whereas sluggish flow is more likely to show contrast opacification in LA/LAA during delayed images. In the subanalysis of those studies in which delayed images were obtained, sensitivity and specificity were 100% and 99%, respectively. Likewise, the PPV significantly increased to 92%, while maintaining a high NPV (ie, 100%) and an overall diagnostic accuracy of 99%. These findings demonstrate that CCT using delayed imaging is a reasonable alternative to TEE for evaluating this patient population. Even though ECG gating definitely improves imaging quality, our sensitivity analysis showed no impact of this technique in the final results. With a prevalence of LA/LAA thrombi/clot ranging between 5% and 15% in patients with nonvalvular AF, the vast majority of patients will have a negative test (ie, 85%-95%). CCT provides a NPV of almost 100%, consequently, precluding the need for further testing before cardioversion or PVI. On the contrary, if a CCT is positive, CCT provides a PPV of 92% (LA/LAA thrombi/clots prevalence 14%) if delayed images are used. Although PPV is not as high as other diagnostic accuracy parameters, it is comparable with the PPV provided by TEE (ie, 86% with LA/LAA thrombi/clot prevalence of 5.2% and 100% with LA/LAA thrombi/clot prevalence of 15%). 10, 11 Therefore, special consideration should be given to CCT for this purpose in patients with persistent AF being evaluated for PVI.
The 2012 Heart Rhythm Society and the European Heart Rhythm Association expert consensus statement on catheter and surgical ablation of AF 45 recommends further characterization of left atrium and pulmonary vein with CCT, CMR, or intracardiac echocardiography for integrated electroanatomic mapping either using the magnet and impedance-based system (CARTO mapping system; CARTO-3) or the electric impedance mapping system (NavX, St. Jude Medical Inc, Minneapolis, MN). Several studies have demonstrated increased efficacy of radiofrequency catheter ablation for AF using integrated electroanatomic mapping. 46, 47 On the basis of these facts, in most tertiary institutions it is a routine practice to perform CCT in patients undergoing PVI for AF. In this particular scenario, CCT may be used to rule out the presence of LA/LAA thrombi/clot and thus avoid the need of a second, unnecessary preprocedural TEE.
In all fairness, CCT has 2 major disadvantages compared with TEE. First of all, CCT examinations required the administration of ≈60 to 120 mL of iodinated contrast agents, which are associated with a risk for contrast-induced nephropathy in patients with underlying kidney disease (ie, serum creatinine, >1.5-2.0 mg/dL) and risk factor, such as diabetes mellitus volume depletion or advanced age. Similarly, in patients who are allergic to iodinated agents, CCT might relatively be contraindicated although they can be premedicated with H1 antihistamines and glucocorticoids. Second, the amount of ionizing radiation to which these patients are exposed is considerably high specially when using 64-slice MDCT and ECG-gating protocols with or without tube current modulation (ie, 9 and 15 mSv, respectively). 48 Likewise, the imaging acquisition with ECG-gated or non-ECG CCT on patients with AF might be challenging sometimes. However, this issue is in part mitigated by the fact that LAA does not move significantly in this rhythm.
Other Imaging Modalities
CMR is also an appealing technique that has gained popularity to evaluate these patients. CMR imaging has also been proposed for the detection of LA/LAA thrombi and compared with TEE using different techniques (ie, 2D perfusion and 3D turbo fast low-angle shot). Only a few studies have been published to date revealing ambiguous results with diagnostic values ranging from sensitivities and specificities of 47% and 50% to almost perfect concordance between CMR and TEE. In addition, the longer time required for examination, higher range of contraindications, and higher procedural costs make CMR a less attractive modality. Similarly, intracardiac echocardiography has been recently proposed and tested for this purpose in patients scheduled for AF ablation showing promising applications, particularly when preprocedural TEE results are inconclusive.
Clinical Implications
In view of having TEE, as the main diagnostic tool for LA/LAA thrombus which carries discomfort and risks, there is growing need to find an alternative test to evaluate for the presence or absence of LA/LAA thrombus in clinical practice. As we have demonstrated in this meta-analysis, CCT with delayed imaging provides very high comparable diagnostic accuracy compared with TEE for detection of LA/LAA thrombus either in patients with persistent or paroxysmal AF undergoing pharmacological/EC or PVI or for the evaluation of cardioembolic source in patients experiencing ischemic CVAs. Special attention should be given in the setting of catheter ablation for AF (PVI), in which preprocedural CCT is routinely ordered to optimize anatomic characterization of the LA and the pulmonary veins (ie, integrated electroanatomical mapping). In this scenario, CCT may be used to rule out LA/LAA thrombi avoiding the need of a second test (TEE), thereby decreasing costs and in-hospital time. Likewise, CCT might also be used as an alternative imaging modality when echocardiography laboratory personnel are not available to perform and interpret a TEE, especially after hours and on weekends.
Study Limitations
Five studies included in this meta-analysis were designed retrospectively. However, they had a high methodological quality and they all met the inclusion criteria (ie, TEE and CCT performed consecutively within 1 week). Furthermore, a detailed sensitivity analysis, including only prospective studies, did not reveal any statistical difference when compared with our results.
Although CCT provides diagnostic accuracy as high as TEE for the detection of thrombus, it does not provide physiological information, such as blood flow velocity of LAA, which might be useful in some cases to guide clinical decision making. Moreover, in patients with known or suspected valvular heart disease, TEE remains the superior diagnostic imaging modality.
Finally, there was a discrepancy when assessing for publication bias using 2 different methods as stated earlier under the publication bias section.
Conclusion
CCT is a reliable alternative imaging modality to TEE for the detection of LA/LAA thrombi/clot in patients with AF before pharmacological/EC, PVI or as an evaluation for cardioembolic source in patients with ischemic CVA avoiding the discomfort and risks associated with TEE.
